An evaluation of progression free survival and overall survival of ovarian cancer patients with clear cell carcinoma versus serous carcinoma treated with platinum therapy: An NRG Oncology/Gynecologic Oncology Group experience.

Oliver KE, Brady WE, Birrer M, Gershenson DM, Fleming G, Copeland LJ, Tewari K, Argenta PA, Mannel RS, Secord AA, Stephan JM, Mutch DG, Stehman FB, Muggia FM, Rose PG, Armstrong DK, Bookman MA, Burger RA, Farley JH

Open source

DOI: 10.1016/j.ygyno.2017.08.004
Published: 2017 Nov
Container: Gynecologic oncology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.ygyno.2017.08.004,
  title = {An evaluation of progression free survival and overall survival of ovarian cancer patients with clear cell carcinoma versus serous carcinoma treated with platinum therapy: An NRG Oncology/Gynecologic Oncology Group experience.},
  author = {Oliver KE and Brady WE and Birrer M and Gershenson DM and Fleming G and Copeland LJ and Tewari K and Argenta PA and Mannel RS and Secord AA and Stephan JM and Mutch DG and Stehman FB and Muggia FM and Rose PG and Armstrong DK and Bookman MA and Burger RA and Farley JH},
  year = {2017},
  journal = {Gynecologic oncology},
  doi = {10.1016/j.ygyno.2017.08.004},
  url = {https://doi.org/10.1016/j.ygyno.2017.08.004}
}

RIS

TY  - JOUR
TI  - An evaluation of progression free survival and overall survival of ovarian cancer patients with clear cell carcinoma versus serous carcinoma treated with platinum therapy: An NRG Oncology/Gynecologic Oncology Group experience.
AU  - Oliver KE
AU  - Brady WE
AU  - Birrer M
AU  - Gershenson DM
AU  - Fleming G
AU  - Copeland LJ
AU  - Tewari K
AU  - Argenta PA
AU  - Mannel RS
AU  - Secord AA
AU  - Stephan JM
AU  - Mutch DG
AU  - Stehman FB
AU  - Muggia FM
AU  - Rose PG
AU  - Armstrong DK
AU  - Bookman MA
AU  - Burger RA
AU  - Farley JH
PY  - 2017
JO  - Gynecologic oncology
DO  - 10.1016/j.ygyno.2017.08.004
UR  - https://doi.org/10.1016/j.ygyno.2017.08.004
ER  -

APA

KE, O., WE, B., M, B., DM, G., G, F., LJ, C., K, T., PA, A., RS, M., AA, S., JM, S., DG, M., FB, S., FM, M., PG, R., DK, A., MA, B., RA, B., & JH, F. (2017). An evaluation of progression free survival and overall survival of ovarian cancer patients with clear cell carcinoma versus serous carcinoma treated with platinum therapy: An NRG Oncology/Gynecologic Oncology Group experience.. Gynecologic oncology. https://doi.org/10.1016/j.ygyno.2017.08.004

Source records

pubmed · retrieved 2026-09-25T15:03:09.512Z